The latest biotechnology news | Bio News
kane-reinholdtsen-LETdkk7wHQk-unsplash

BIO Patient Advocacy Coffee Chat: Act now to be heard on CMS drug pricing

The Medicare drug price “negotiation” process has entered its third year, with some ...
Read More
denys-kostyuchenko-FQjUaIMQF3Q-unsplash

Meet us in Miami for the BIO Investment and Growth Summit

The inaugural Biotechnology Innovation Organization (BIO) Investment and Growth (BIG) Summit kicks off ...
Read More
drug price negotiation

BIO warns MFN models are illegal, ineffective, and a threat to innovation

Proposals to let decisions by other countries control American drug prices are illegal, ...
Read More
rachel-coyne-U7HLzMO4SIY-unsplash

Music Beats Cancer aims to bring everyone to the stage

The Valley of Death is a healthcare crisis, but the nonprofit, Music Beats ...
Read More
towfiqu-barbhuiya-joqWSI9u_XM-unsplash (1)

The BIG Summit meets at the intersection of patient advocacy and venture investment

Patient advocacy organizations that leverage venture philanthropy—an approach to philanthropic giving that applies ...
Read More
caglar-oskay-ED_4-IQyqqE-unsplash

BIO Coffee Chat: MFN proposals would harm innovation and access

Most Favored Nation (MFN) type drug pricing proposals that were proposed by the ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Crowley PBMs

BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices

Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Read More

LATEST NEWS

Federal Policy

BIO Patient Advocacy Coffee Chat: Act now to be heard on CMS drug pricing

The Medicare drug price “negotiation” process has entered its third year, with some evolution but continued complexity for patients and patient organizations. This year, 15 ...
Latest News

Meet us in Miami for the BIO Investment and Growth Summit

The inaugural Biotechnology Innovation Organization (BIO) Investment and Growth (BIG) Summit kicks off on March 2, 2025, and will convene industry leaders in sunny Miami ...
Latest News

BIO warns MFN models are illegal, ineffective, and a threat to innovation

Proposals to let decisions by other countries control American drug prices are illegal, would reduce the availability of innovative new treatments, and fail to help ...
Health

Music Beats Cancer aims to bring everyone to the stage

The Valley of Death is a healthcare crisis, but the nonprofit, Music Beats Cancer, has an innovative way to help solve it, and it starts ...
BIO Events

The BIG Summit meets at the intersection of patient advocacy and venture investment

Patient advocacy organizations that leverage venture philanthropy—an approach to philanthropic giving that applies venture capital principles to achieve philanthropic goals—can provide vital funding sources for ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top